重磅發佈 - 君聖泰醫藥在JAMA Network Open發表熊去氧膽小檗鹼治療2型糖尿病的臨床2期研究數據 療效顯著 多重代謝獲益 市場前景廣闊
Mar 04, 2025 16:48 HKT |  |
|
重磅发布 - 君圣泰医药在JAMA Network Open发表熊去氧胆小檗碱治疗2型糖尿病的临床2期研究数据 疗效显著 多重代谢获益 市场前景广阔
Mar 04, 2025 12:32 HKT | |
|
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open
Mar 04, 2025 12:26 HKT | |
|
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Mar 03, 2025 14:50 HKT |  |
|
華領醫藥榮獲上海市創新型企業總部授牌
Mar 03, 2025 13:55 HKT | |
|
华领医药荣获上海市创新型企业总部授牌
Mar 03, 2025 13:46 HKT | |
|
迪拜高层代表团一行参访君圣泰医药 解码中国医药创新范式
Feb 27, 2025 21:01 HKT | |
|
CGFNS International 將更名為 TruMerit
Feb 26, 2025 15:00 HKT |  |
|
雲頂新耀發佈伊曲莫德（VELSIPITY(R)）完整維持期數據 創新研發實力再獲認可
Feb 26, 2025 14:21 HKT | |
|
云顶新耀发布伊曲莫德（VELSIPITY(R)）完整维持期数据 创新研发实力再获认可
Feb 26, 2025 14:18 HKT | |
|
CGFNS International to Change Its Name to TruMerit
Feb 26, 2025 07:00 HKT | |
|
Goldman Sachs Raises Everest Medicines' Target Price to HK$48.32 on Stronger Commercial and R&D Outlook
Feb 19, 2025 14:42 HKT | |
|
高盛上調雲頂新耀目標價至48.32港元 認可其商業化進程加速
Feb 19, 2025 14:33 HKT | |
|
高盛上调云顶新耀目标价至48.32港元 认可其商业化进程加速
Feb 19, 2025 14:25 HKT | |
|
康哲藥業（867.HK）入選標普全球《可持續發展年鑒2025》
Feb 14, 2025 12:26 HKT |  |
|
康哲药业（867.HK）入选标普全球《可持续发展年鉴2025》
Feb 14, 2025 12:11 HKT | |
|
CGFNS International 报告称 2024 年赴美护士移民率仍然较高
Feb 12, 2025 11:00 HKT | |
|
CGFNS International 報告指出 2024 年赴美護理移民率仍較高
Feb 12, 2025 11:00 HKT | |
|
CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024
Feb 12, 2025 08:00 HKT | |
|
An Incredible KLAS Triple-Award Win for AGFA HealthCare!
Feb 10, 2025 22:00 HKT |  |
|